COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients

BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious impact on public health worldwide. Most patients develop mild to moderate symptoms and recover without requiring special treatment, but up to 15% develop severe (dyspnea, hypoxia, lung involvement) or critical symptom...

Descripción completa

Detalles Bibliográficos
Autor principal: Bellino, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586661/
https://www.ncbi.nlm.nih.gov/pubmed/36259490
http://dx.doi.org/10.1080/07853890.2022.2133162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586661/
https://www.ncbi.nlm.nih.gov/pubmed/36259490
http://dx.doi.org/10.1080/07853890.2022.2133162

Ejemplares similares